Administering antiviral drugs earlier may reduce mortality risk for HIV patients, research suggests. Bloomberg News (4/2, Waters) reports, “Patients who start antiviral drugs before their immune systems are damaged by the AIDS virus substantially cut their risk of death,” according to a study led by University of Washington researchers and published in the New England Journal of Medicine. Specifically, those “who started treatment before their infection-fighting cells had [...]
Source: feedproxy.google.comSouth Asians With Diabetes More Likely To Lose Their Eyesight Earlier Than White Europeans South Asians with type 2 diabetes are significantly more at risk of losing their eyesight and losing it at an earlier age, compared to White Europeans with the same condition. A UK study carried out by the University of Warwick shows diabetic retinopathy (damage to the retina) is more prevalent in South Asians and occurs earlier than in White European people with diabetes. The study, published in the latest issue of Diabetes Care, looked at 1.
Source: www.medicalnewstoday.comUrologist, J. Francois Eid, M.D., Lauds Improvements In Penile Prosthesis And Artificial Urinary Sphincter Technologies Dr. J. Francois Eid has performed more internal penile implant surgeries than anyone in the world and has built a reputation for excellence in the treatment of erectile dysfunction (ED).
Source: www.medicalnewstoday.comMore Americans seen failing to fill prescriptions. The Wall Street Journal (4/8, Rockoff) reports, “More Americans are failing to fill prescriptions because of the economic downturn, according to market research” from health-information company Wolters Kluwer Health. “
Prescription-drug sales are usually immune to the economy’s ups and downs, but the data…indicate that the current recession is having an unusually negative impact.” The research [...]
Source: feedproxy.google.comResearch suggests stopping rosiglitazone use may cause higher blood glucose levels. HealthDay (4/16, Preidt) reported that, according to a study published in the journal Endocrine Practice, “many patients who stopped using the diabetes drug rosiglitazone (Avandia) due to concerns about the drug’s safety received less treatment and developed higher blood glucose levels.” For the study, researchers from the University of Texas Health Science Center found that [...]
Source: feedproxy.google.comSciele Pharma, Inc. Announce Completion Of Patient Recruitment For Global Phase III Trial Of PSD502 For Premature Ejaculation Sciele Pharma, Inc., a Shionogi company, and Plethora Solutions Holdings PLC ("Plethora," AIM: PLE), today announced the completion of patient recruitment of the PSD502 registration program for the treatment of premature ejaculation (PE). The preliminary results from this North American study are expected in mid-year 2009. A parallel European Phase III study of PSD502 concluded successfully in November 2008 with a positive outcome that was both clinically and statistically significant.
Source: www.medicalnewstoday.comLaser Spine Institute Helps Professionals Take Back Their Lives From Debilitating Back Pain With 4.2 million administrative professionals logging long hours at their desks, it's not surprising insurance companies dish out $50 billion a year to Americans suffering from back pain. This Administrative Professionals Day, observed April 22, the Laser Spine Institute is helping administrative support professionals find relief. Simple changes in daily activities can often alleviate pain without the need for surgery. LSI Director of Physical Therapy, Irene Rademeyer PT.OCS.
Source: www.medicalnewstoday.comRexahn Completes Patient Enrollment In Phase IIa Clinical Trial Of ZoraxelTM To Treat Erectile Dysfunction Rexahn Pharmaceuticals, Inc. (NYSE Alternext US: RNN), a leader in development of innovative therapeutics for life-threatening and life-debilitating diseases, announced the completion of enrollment in its Phase IIa clinical trial evaluating ZoraxelTM for treatment of Erectile Dysfunction (ED). The Company expects to have preliminary study results in March 2009.
Source: www.medicalnewstoday.com
# posted by Network @ 2:20 AM
